Fox Chase clinical trial tests first of its kind antibody

Links shared publicly online about this topic.

1,118
total visits

Fox Chase clinical trial tests first of its kind antibody

Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem in mind, Fox Chase Cancer Center researchers are testing a novel type of antibody called MM-111 in patients with HER2-positive disease who have progressed ...

View full resource at physorg.com

Tags: Cancer, Disease and Condition, Drug, Clinical Trial, Mind and Spirit